Fibromyalgia

Axial Psoriatic Arthritis and Ankylosing Spondylitis: Comparing Clinical, Radiologic Characteristics

It is unclear whether ankylosing spondylitis and axial psoriatic arthritis are part of a spectrum of the same disease, or whether they are separate diseases ...

Hitting the Target in Psoriatic Arthritis: Which Outcome Measures Are Best?

Experts are still debating the utility of a unidimensional composite score compared with a multidimensional score for the assessment of disease activity in psoriatic arthritis.

Challenges of Targeting Remission in Axial Spondyloarthritis

Current guidelines define remission as the absence of clinical and laboratory evidence of significant inflammatory disease, but the tools that are currently available are inadequate ...

EULAR/PReS Standards for Transitional Care of Juvenile-Onset Rheumatic Diseases

Panel advises that up to 50% of young patients with juvenile-onset rheumatic diseases fail to successfully transition to adult rheumatology services.

Clinician Roundtable: Effective Management of Noninfectious Uveitis

Autoimmune uveitis is usually a diagnosis of exclusion. Part of the challenge of effective management of noninfectious uveitis is that it is not really a ...

Video Review: Differentiating Septic and Reactive Arthritis

Seronegative spondyloarthropathies associated with human leukocyte antigen (HLA) B27 antigens can manifest as an acute inflamed joint and must be differentiated from septic arthritis.

Lead Investigator Discusses Phase 3 Trial of IL-17A Inhibitor in PsA

Philip Mease, MD, clinical professor, University of Washington School of Medicine, Seattle, discusses the treatment of psoriatic arthritis (PsA) by inhibiting interleukin (IL)-17A with the ...

When Should Rheumatologists Refer Patients for Evaluation by an Orthopedic Surgeon?

Michael M. Alexiades, MD, met with Rheumatology Advisor to discuss the timely referral of patients with inflammatory arthritides who may be candidates for operative intervention.

Evaluation of the Pediatric Patient With Joint Pain and Swelling

Watch a video providing a comprehensive review of the distinguishing factors between the presentation of septic arthritis and Lyme arthritis.

VIDEO: Discussing the Use of Biosimilars for Rheumatic Disease

Discussion of the recent introduction of biosimilar agents into the treatment armamentarium for rheumatic disease.

Latest News

EULAR 2018 Coverage Early, Sustained Improvements With Apremilast in Biologic-Naive Psoriatic Arthritis

Early, Sustained Improvements With Apremilast in Biologic-Naive Psoriatic Arthritis

In biologic-naive patients with psoriatic arthritis who are treated with apremilast, early onset of effect was observed across disease PsA manifestations.

EULAR 2018 Coverage Glucocorticoid Cumulative Dose Has No Effect on BMD, Fracture Risk in Psoriasis, PsA

Glucocorticoid Cumulative Dose Has No Effect on BMD, Fracture Risk in Psoriasis, PsA

The objective of this cross-sectional analysis was to evaluate the prevalence of osteoporosis and frequency of fractures in patients with psoriasis or psoriatic arthritis.

EULAR 2018 Coverage NSAID, TNFi Combination May Reduce Radiographic Progression in Ankylosing Spondylitis

NSAID, TNFi Combination May Reduce Radiographic Progression in Ankylosing Spondylitis

Dose-related use of NSAIDs together with TNFi in patients with ankylosing spondylitis has a synergistic effect in slowing radiographic progression.

Spondyloarthritis Biologic Therapy in Ankylosing Spondylitis: Insights From Social Media

Biologic Therapy in Ankylosing Spondylitis: Insights From Social Media

Researchers used data from social media to identify concerns and perceptions regarding biologic therapies.

Spondyloarthritis Reduced Structural Damage in Early Axial Spondyloarthritis Linked to Increased IL-31 Levels

Reduced Structural Damage in Early Axial Spondyloarthritis Linked to Increased IL-31 Levels

Increased interleukin-31 levels may protect against structural damage in patients with axial spondyloarthritis.

Spondyloarthritis Extended Disease Duration Increases Risk for IBD, Uveitis in Axial Spondyloarthritis

Extended Disease Duration Increases Risk for IBD, Uveitis in Axial Spondyloarthritis

Axial spondyloarthritis disease duration was associated with higher risk of developing acute anterior uveitis and inflammatory bowel disease, but not psoriasis.

Spondyloarthritis High Rate of Hidradenitis Suppurativa Observed in Patients With Axial Spondyloarthritis

High Rate of Hidradenitis Suppurativa Observed in Patients With Axial Spondyloarthritis

Hidradenitis suppurativa is more common in patients with axial spondyloarthritis compared with the general population.

Ankylosing Spondylitis Tofacitinib Reduces MRI Inflammation, May Improve Outcomes in Ankylosing Spondylitis

Tofacitinib Reduces MRI Inflammation, May Improve Outcomes in Ankylosing Spondylitis

Researchers assessed achievement of minimally important changes in SPARCC scores in biologic-naive patients with ankylosing spondylitis treated with tofacitinib or placebo.

Psoriatic Arthritis Baseline Characteristics Associated With Response to Biologic Therapy in PsA

Baseline Characteristics Associated With Response to Biologic Therapy in PsA

Researchers sought to compare baseline characteristics between patients with PsA who achieved and did not achieve minimal disease activity with biologic therapy.

Ankylosing Spondylitis Factors Associated With Neuropathic Pain in Ankylosing Spondylitis

Factors Associated With Neuropathic Pain in Ankylosing Spondylitis

A number of factors that include age, the presence of enthesitis, and depressive symptoms may be associated with neuropathic pain in ankylosing spondylitis.

Sign Up for Free e-newsletters